• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Daily Derm Times: April 22, 2025

Key Takeaways

  • LEO Pharma's survey reveals significant emotional and occupational challenges for chronic hand eczema patients, highlighting widespread misunderstandings.
  • Palvella's 5th US patent for Qtorin rapamycin extends intellectual property coverage to 2038, advancing treatment for microcystic lymphatic malformations.
SHOW MORE

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Survey Unveils Impact of Chronic Hand Eczema on Patients’ Lives and Treatment Landscape

A survey by LEO Pharma indicates widespread misunderstandings about chronic hand eczema, revealing significant emotional and occupational challenges for patients.

Palvella Secures New US Patent for Qtorin Rapamycin in Microcystic Lymphatic Malformations

Palvella has secured its 5th US patent for Qtorin rapamycin, extending intellectual property coverage to 2038 and advancing treatment for microcystic lymphatic malformations.

Teledermatology Preferences Among Patients with Psoriasis

Continuity with a known physician and rapid response times significantly increased patient willingness to use teledermatology.

Redefining Anti-Aging with Regenerative Aesthetics and Growth Factor Skincare

Prithwiraj Maitra, PhD, Vice President of Global Skincare R&D at Allergan Aesthetics, gave his thoughts on regenerative aesthetics and other recent skincare advancements.

Isotretinoin Often Continued Despite Mood Concerns

Despite early psychological symptoms, over half of patients in the study completed their full treatment course.

Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes

Researchers conduct a review to understand the efficacy and safety of topical minocycline for the treatment of moderate to severe papulopustular rosacea.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.